Ibuprofen Tablets Recalled Due to Failed Impurities and Degradation Specifications
Preferred Pharmaceuticals is recalling 266 bottles of generic ibuprofen tablets due to failed impurities and degradation specifications discovered during stability testing. The affected lots were distributed in California and Nevada.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for pharmaceutical product quality failures (impurities and degradation specifications). The rubric applies Score 3 to risk-of-harm products where injury has not yet been reported, which matches this situation.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling Ibuprofen Tablets, USP 400mg (generic for Motrin) in 30-tablet bottles due to failed impurities and degradation specifications. The recall involves 266 bottles with lot codes B0223H (expires 5/31/2026) and C3023H (expires 9/30/2026). The product was manufactured by Dr. Reddy's Laboratories in Shreveport, Louisiana, and distributed in California and Nevada.
The product failed impurities and degradation specifications during 18-month stability testing.
Consumers with this product should contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug — Ibuprofen / Tablet
- Hazard
- impurities
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: B0223H
- Exp: 5/31/2026
- C3023H
- Exp: 9/30/2026.
Distribution
Distributed in 2 states:
- CA
- NV
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01